While IgA levels in the NALF were comparable to or slightly lower than those in the BALF, the results collectively demonstrated that the mosaic H1N1 LAIV elicited robust mucosal antibody responses in both the upper and lower respiratory tracts, targeting both homologous and heterologous influenza subtypes. Here, CD79A is linked to influenza.